Pilot Assessment of EyeArt as an Automated Diabetic Retinopathy Screening Tool
| Status: | Completed |
|---|---|
| Conditions: | Ocular, Diabetes |
| Therapuetic Areas: | Endocrinology, Ophthalmology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 8/1/2018 |
| Start Date: | February 17, 2017 |
| End Date: | April 24, 2017 |
More than 29 million people in the US are living with diabetes, many of whom will develop
diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and
blindness in working-age adults. Annual eye screening is recommended for all diabetic
patients since vision loss can be prevented with laser photocoagulation and anti-VEGF
injections if DR is diagnosed in its early stages. Currently, the number of clinical
personnel trained for DR screening is orders of magnitude smaller than that needed to screen
the large, growing diabetic population. Therefore, to meet this large unmet need for DR
screening, a fully-automated computerized DR screening system is necessary. This study is
designed to assess the performance of EyeArt, an automated DR screening tool.
diabetic retinopathy (DR) or diabetic eye disease (DED), the leading cause of vision loss and
blindness in working-age adults. Annual eye screening is recommended for all diabetic
patients since vision loss can be prevented with laser photocoagulation and anti-VEGF
injections if DR is diagnosed in its early stages. Currently, the number of clinical
personnel trained for DR screening is orders of magnitude smaller than that needed to screen
the large, growing diabetic population. Therefore, to meet this large unmet need for DR
screening, a fully-automated computerized DR screening system is necessary. This study is
designed to assess the performance of EyeArt, an automated DR screening tool.
Inclusion Criteria:
- 18 years of age or older;
- a diagnosis of diabetes mellitus; and
- understanding of study and provision of written informed consent.
Exclusion Criteria:
- Persistent visual impairment or sudden vision loss in one or both eyes;
- History of uncorrected media opacity in one or both eyes;
- History of retinal vascular disease other than diabetic eye disease;
- History of ocular injections, laser treatment of the retina, or intraocular surgery
other than cataract;
- Subject has contraindications for mydriatic medications or is unwilling or unable to
dilate;
- Subject is currently enrolled in an interventional study of an investigational
device/drug; or
- Subject has a condition or is in a situation which in the opinion of the Investigator,
might confound study results, may interfere significantly with the subject's
participation in the study, or result in ungradable 4-wide field stereoscopic
mydriatic fundus photographs.
We found this trial at
1
site
Click here to add this to my saved trials
